🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations Joel Tarning

Oxford’s research endeavour stretches beyond tropical medicine. Research across our full disciplinary power is coming together to tackle global health challenges ➡️ globalhealth.ox.ac.uk Come chat to me or Jo Miller to find out more #OTN2024 7/7

#MIM2024

#MIM2024

To avoid haemolysis in #G6PD deficient infants, treating breastfeeding mothers w/primaquine is not advised. But kids have <1% of mom's primaquine exposure, so significant haemolysis highly unlikely: Primaquine s/d not be restricted for breastfeeding women go.nature.com/4c0Lyjx

Good news! No evidence of sub-optimal #malaria treatment or substantial changes in pharmacokinetic PK properties of ACT partner drugs amodiaquine & piperaquine during pregnancy. Dose adjustment NOT warranted for women in 2nd/3rd trimester of pregnancy! bit.ly/4dSvpy5

In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever - Ding - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library ascpt.onlinelibrary.wiley.com/doi/10.1002/ps…

New insights into #dengue! In-host dengue kinetic model quantitatively predicts dengue fever drug effects, offers valuable insights to inform dengue drug development and shows that #Ivermectin reduces NS1 but not viral load Learn more! bit.ly/407X627 Photo @LukeDuggleby

Attending #ASTMH2024? Be part of the Neglected Tropical Diseases symposium on Thursday 14th at 10 AM. The team will extensively discuss drug development, clinical trials, and #pharmacometrics when treating pregnant & breastfeeding women. ASTMH Global Institute for Disease Elimination MORU H3D Foundation

Pharmacometric and statistical considerations for dose optimization doi.org/10.1002/psp4.1…

Congratulations to Joel Tarning, just named Distinguished International Fellow at #astmh2024. Joel was recognized for "his exceptional scholarly accomplishments [&] global leadership antimalarial pharmacology." Well done, Joel! astmh.org/awards-fellows…

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure pubmed.ncbi.nlm.nih.gov/39334094/

ascpt.onlinelibrary.wiley.com/doi/full/10.10…

#ResearchHighlight from Joel Tarning MORU Dose-optimization of a novel co-formulated triple combination #antimalarial therapy: artemether-lumefantrine-amodiaquine Read more 👉 ndm.ac/tropmed.res-hi Full publication 👉 ascpt.onlinelibrary.wiley.com/doi/10.1002/cp…